logo

For the Inventor, By the Inventor

Parsippany, NJ, United States of America

Chase Pharmaceuticals Corporation


USPTO Granted Patents = 14



Forward Citations = 81

Loading Chart...
Loading Chart...

5 inventors (with patents filed for the assignee):

goldMedal Thomas N Chase (14 out of 28 patents)

silverMedal Kathleen E Clarence-Smith (14 out of 32 patents)


14 patents:

1. 10596139 - Oxybutynin transdermal therapeutic system muscarinic agonist combination (2020-03-24),
2. 10548855 - Memantine combinations and use (2020-02-04),
3. 10307409 - Muscarinic combinations and their use for combating hypocholinergic disorders of the central nervous system (2019-06-04),
4. 10195187 - Oxybutynin-xanomeline transdermal therapeutic system combinations (2019-02-05),
5. 10149828 - Oxybutynin transdermal therapeutic system combination (2018-12-11),
6. 9943508 - Method and composition for treating Alzheimer-type dementia (2018-04-17),
7. 9913836 - Anticholinergic neuroprotective composition and methods (2018-03-13),
8. 9744161 - Method and composition for treating alzheimer-type dementia (2017-08-29),
9. 9561218 - Anticholinergic neuroprotective composition and methods (2017-02-07),
10. 9278092 - Method and composition for treating alzheimer-type dementia (2016-03-08),
11. 9192591 - Method and composition for treating alzheimer-type dementia (2015-11-24),
12. 9044472 - Use and composition for treating dementia (2015-06-02),
13. 8877768 - Method and composition for treating alzheimer-type dementia (2014-11-04),
14. 8404701 - Use and composition for treating dementia (2013-03-26),
Chase Pharmaceuticals Corporation is a biotech company dedicated to the development and commercialization of innovative therapies for the treatment of neurodegenerative disorders. With a focus on Alzheimer's disease, Chase Pharmaceuticals is committed to improving the lives of patients and caregivers by addressing the unmet medical needs in this field. Their groundbreaking research and drug development efforts aim to provide effective and safe treatments to slow or halt the progression of neurodegenerative diseases.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

14 Patents

#33 in Parsippany, NJ

#839 in New Jersey

#21,598 in US

#40,882 in the World

...
Parsippany, NJ, United States of America

Chase Pharmaceuticals Corporation

Forward Citations = 81

5 inventors:

goldMedal Thomas N Chase (14 out of 28 patents)

silverMedal Kathleen E Clarence-Smith (14 out of 32 patents)

Please report any incorrect information to support@idiyas.com
Loading…